Overview

A Study of Ustekinumab in Pediatric Participants

Status:
Recruiting
Trial end date:
2023-10-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate pharmacokinetics (PK) of ustekinumab in juvenile psoriatic arthritis (jPsA) and pediatric psoriasis (PsO).
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Ustekinumab